Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study - PubMed (original) (raw)
Randomized Controlled Trial
doi: 10.1097/01.mao.0000265190.29969.12.
Hiroyuki Yamada, Hisashi Kohno, Shuichi Matsumoto, Nobumitsu Honda, Kiyofumi Gyo, Satoshi Fukuda, Yasushi Furuta, Fumio Ohtani, Hiroshi Aizawa, Masaru Aoyagi, Hiroo Inamura, Tsutomu Nakashima, Seiichi Nakata, Shingo Murakami, Jun Kiguchi, Koji Yamano, Taizo Takeda, Masashi Hamada, Kazuhiro Yamakawa
Affiliations
- PMID: 17414047
- DOI: 10.1097/01.mao.0000265190.29969.12
Randomized Controlled Trial
Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study
Naohito Hato et al. Otol Neurotol. 2007 Apr.
Abstract
Objective: To investigate the effects of valacyclovir and prednisolone in comparison with those of placebo and prednisolone for the treatment of Bell's palsy, excluding zoster sine herpete.
Study design: Prospective, multicenter, randomized placebo-controlled study.
Setting: Six academic tertiary referral centers.
Patients: Ultimately, 221 patients with Bell's palsy who were treated within 7 days of the onset. Serological and polymerase chain reaction examinations were performed to distinguish Bell's palsy from zoster sine herpete.
Intervention: The patients were treated with either valacyclovir (dosage, 1,000 mg/d for 5 days) plus prednisolone (VP [n = 114]) or placebo plus prednisolone (PP [n = 107]) administered orally.
Main outcome measure: Recovery from the palsy was defined as a score higher than 36 using Yanagihara 40-point scoring system without facial contracture or synkinesis. The patients were followed up until complete recovery occurred or for more than 6 months in cases with a poor prognosis.
Results: The overall rate of patient recovery among those treated with VP (96.5%) was significantly better (p < 0.05) than the rate among those treated with PP (89.7%). The rate of patient recovery was also analyzed by classifying the initial severity of facial palsy. In cases of complete or severe palsy, the rates of patients treated with VP and PP who recovered were 95.7% (n = 92) and 86.6% (n = 82), respectively; the recovery rate for treatment with VP was significantly better than that with PP (p < 0.05).
Conclusion: The valacyclovir and prednisolone therapy was more effective in treating Bell's palsy, excluding zoster sine herpete, than the conventional prednisolone therapy. To our knowledge, this is the first controlled study of an antiviral agent in the treatment of a sufficient number of Bell's palsy cases based on an etiologic background.
Similar articles
- The course of pain in Bell's palsy: treatment with prednisolone and valacyclovir.
Berg T, Axelsson S, Engström M, Stjernquist-Desatnik A, Pitkäranta A, Kanerva M, Jonsson L. Berg T, et al. Otol Neurotol. 2009 Sep;30(6):842-6. doi: 10.1097/MAO.0b013e3181ab31c8. Otol Neurotol. 2009. PMID: 19503012 Clinical Trial. - Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell's palsy.
Kawaguchi K, Inamura H, Abe Y, Koshu H, Takashita E, Muraki Y, Matsuzaki Y, Nishimura H, Ishikawa H, Fukao A, Hongo S, Aoyagi M. Kawaguchi K, et al. Laryngoscope. 2007 Jan;117(1):147-56. doi: 10.1097/01.mlg.0000248737.65607.9e. Laryngoscope. 2007. PMID: 17202945 Clinical Trial. - The effect of study design and analysis methods on recovery rates in Bell's palsy.
Berg T, Marsk E, Engström M, Hultcrantz M, Hadziosmanovic N, Jonsson L. Berg T, et al. Laryngoscope. 2009 Oct;119(10):2046-50. doi: 10.1002/lary.20626. Laryngoscope. 2009. PMID: 19653268 Clinical Trial. - Antiviral treatment for Bell's palsy (idiopathic facial paralysis).
Gagyor I, Madhok VB, Daly F, Somasundara D, Sullivan M, Gammie F, Sullivan F. Gagyor I, et al. Cochrane Database Syst Rev. 2015 Nov 9;(11):CD001869. doi: 10.1002/14651858.CD001869.pub8. Cochrane Database Syst Rev. 2015. PMID: 26559436 Review. - WITHDRAWN. Antiviral treatment for Bell's palsy (idiopathic facial paralysis).
Gagyor I, Madhok VB, Daly F, Somasundara D, Sullivan M, Gammie F, Sullivan F. Gagyor I, et al. Cochrane Database Syst Rev. 2015 May 4;(5):CD001869. doi: 10.1002/14651858.CD001869.pub5. Cochrane Database Syst Rev. 2015. PMID: 25938618 Updated. Review.
Cited by
- Optimal Bell's Palsy Treatment: Steroids, Antivirals, and a Timely and Personalized Approach.
Rim HS, Byun JY, Kim SH, Yeo SG. Rim HS, et al. J Clin Med. 2023 Dec 21;13(1):51. doi: 10.3390/jcm13010051. J Clin Med. 2023. PMID: 38202059 Free PMC article. - Comparison of Medical and Surgical Treatment in Severe Bell's Palsy.
Kim Y, Yeo SG, Rim HS, Lee J, Kim D, Kim SS, Park DC, Byun JY, Kim SH. Kim Y, et al. J Clin Med. 2022 Feb 8;11(3):888. doi: 10.3390/jcm11030888. J Clin Med. 2022. PMID: 35160337 Free PMC article. - Clinical Prognostic Factors Associated with Good Outcomes in Pediatric Bell's Palsy.
Yoo MC, Park DC, Byun JY, Yeo SG. Yoo MC, et al. J Clin Med. 2021 Sep 24;10(19):4368. doi: 10.3390/jcm10194368. J Clin Med. 2021. PMID: 34640384 Free PMC article. - Steroids plus antiviral agents are more effective than steroids alone in the treatment of severe Bell's palsy patients over 40 years of age.
Kim Y, Doo JG, Chon J, Lee JH, Jung J, Lee JM, Kim SH, Yeo SG. Kim Y, et al. Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211042124. doi: 10.1177/20587384211042124. Int J Immunopathol Pharmacol. 2021. PMID: 34633253 Free PMC article. - Association between Initial Severity of Facial Weakness and Outcomes of Bell's Palsy.
Yoo MC, Park DC, Yeo SG. Yoo MC, et al. J Clin Med. 2021 Aug 30;10(17):3914. doi: 10.3390/jcm10173914. J Clin Med. 2021. PMID: 34501363 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous